Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- José Luís González Larriba, MD
SOGUG
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Clinic
Barcelona, Barcelona, Spain
- Hospital Parc Taulí
Sabadell, Barcelona, Spain
- Hospital Reina Sofía
Córdoba, Córdoba, Spain
- Hospital de Jaén
Jaén, Jaén, Spain
- Hospital Clínico San Carlos
Madrid, Madrid, Spain
- Hospital Central de Asturias
Oviedo, Principality of Asturias, Spain
- Hospital Lozano Blesa
Zaragoza, Zaragoza, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2008
- Primary completion
- 31 Aug 2009
- Completion
- 28 Feb 2010
- Last update posted
- 18 Dec 2014
- Registered enrollment
- 59
- Registry id
- NCT00663559
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.